1 study found for:    nivolumab and yervoy | Phase 3
Show Display Options
Rank Status Study
1 Active, not recruiting Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067)
Condition: Unresectable or Metastatic Melanoma
Interventions: Biological: Nivolumab;   Biological: Ipilimumab;   Biological: Placebo for Nivolumab;   Biological: Placebo for Ipilimumab

Indicates status has not been verified in more than two years